News & Analysis on Clinical Trial Services & Contract Research And Development
Chiron has said it will be unable to meet its projections for flu vaccine production this year, because it has been unable to get production back up to speed at its manufacturing facility in Liverpool, UK, as quickly as hoped. The news has also...
Researchers have claimed that a fragment of the deadly yellow fever virus may hold the key to a safer and more effective vaccine, bringing hope to the 200,000 victims a year. Currently, no drug treatment is effective against the virus.
Affymetrix has announced the launch of a scanner, which enables analysis of microarrays that feature 500 per cent more data than previous generations making it highly suitable for drug development applications such as RNA expression and DNA analysis.